These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10414296)

  • 1. Lambert-Eaton antibodies promote activity-dependent enhancement of exocytosis in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    Ann N Y Acad Sci; 1999 Apr; 868():213-6. PubMed ID: 10414296
    [No Abstract]   [Full Text] [Related]  

  • 2. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of the Lambert-Eaton syndrome antibodies. Downregulation of P/Q-type calcium channels in bovine adrenal chromaffin cells.
    Kim YI; Nam TS; Kim SH; Viglione MP; Kim J
    Ann N Y Acad Sci; 1998 May; 841():677-83. PubMed ID: 9668313
    [No Abstract]   [Full Text] [Related]  

  • 4. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
    Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
    Peers C; Johnston I; Lang B; Wray D
    Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
    Blandino JK; Kim YI
    Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
    Viglione MP; O'Shaughnessy TJ; Kim YI
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
    Pinto A; Moss F; Lang B; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():687-90. PubMed ID: 9668315
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of Lambert-Eaton syndrome IgG on calcium currents in a thyroid C-cell line.
    Kim YI; Blandino JK; O'Shaughnessy TJ
    Ann N Y Acad Sci; 1993 Jun; 681():398-401. PubMed ID: 8395154
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
    Honnorat J
    Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
    Giovannini F; Sher E; Webster R; Boot J; Lang B
    Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels.
    Kim YI; Neher E
    Science; 1988 Jan; 239(4838):405-8. PubMed ID: 2447652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.
    Cetin H; Vincent A
    Semin Neurol; 2018 Jun; 38(3):344-354. PubMed ID: 30011414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.
    Engel AG
    Ann N Y Acad Sci; 1991; 635():246-58. PubMed ID: 1660237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.